HCPCS Level II
J1956
Injection, levofloxacin, 250 mg
Codes near J1956
These sit next to J1956 in the CMS Level II file. All J codes
- J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
- J1952Leuprolide injectable, camcevi, 1 mg
- J1953Injection, levetiracetam, 10 mg
- J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
- J1955Injection, levocarnitine, per 1 gm
- J1957Injection, levetiracetam, 5 mg
- J1958Injection, levetiracetam in sodium chloride, 5 mg
- J1960Injection, levorphanol tartrate, up to 2 mg
- J1961Injection, lenacapavir (only for use as hiv treatment), 1 mg
- J1980Injection, hyoscyamine sulfate, up to 0.25 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9315-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 24 |
| 00143-9316-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 48 |
| 00143-9317-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 72 |
| 00143-9720-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 72 |
| 00143-9721-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 48 |
| 00143-9722-24 | Levofloxacin | Hikma Pharmaceuticals USA Inc. | 24 |
| 00409-2220-24 | Levofloxacin | Pfizer Inc | 24 |
| 00409-3330-24 | Levofloxacin | Pfizer Inc | 48 |
| 00409-4444-24 | Levofloxacin | Pfizer Inc | 72 |
| 25021-0132-81 | Levofloxacin | Sagent Pharmaceuticals | 24 |
| 25021-0132-82 | Levofloxacin | Sagent Pharmaceuticals | 48 |
| 25021-0132-83 | Levofloxacin | Sagent Pharmaceuticals | 72 |
| 44567-0435-24 | Levofloxacin | WG Critical Care, LLC | 24 |
| 44567-0436-24 | Levofloxacin | WG Critical Care, LLC | 48 |
| 44567-0437-24 | Levofloxacin | WG Critical Care, LLC | 72 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.